Paysign (Nasdaq:PAYS) - 주가, 뉴스 및 분석

PAYS 주식 개요

는 기업, 소비자 및 정부 기관을 위한 선불 카드 프로그램, 포괄적인 환자 경제성 제품, 디지털 뱅킹 서비스 및 통합 결제 처리 서비스를 제공합니다. 자세한 내용

PAYS 기본 분석
눈송이 점수
가치 평가	2/6
미래 성장	1/6
과거 실적	6/6
재무 상태	6/6
배당금	0/6

보상

수익은 연간 10.55% 증가할 것으로 예상됩니다.

지난 1년간 수익이 420.5% 증가했습니다.

분석가들은 주가가 106.4% 상승할 것이라는 데 동의합니다.

위험 분석

수익은 향후 3년간 연평균 24.1% 씩 감소할 것으로 예상됩니다.

지난 3개월간 상당한 내부자 매도

Paysign, Inc. 경쟁사

Cass Information Systems

NasdaqGS:CASS

US$601.0m

International Money Express

NasdaqCM:IMXI

US$651.2m

Cantaloupe

NasdaqGS:CTLP

US$653.2m

Usio

NasdaqGM:USIO

US$40.2m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Paysign
과거 주가
현재 주가	US$3.30
52주 최고치	US$5.59
52주 최저치	US$2.22
베타	0.96
11개월 변경	-12.00%
3개월 변경 사항	-29.49%
1년 변경 사항	41.03%
33년 변화	64.18%
5년 변화	-68.21%
IPO 이후 변화	633.33%

최근 뉴스 및 업데이트

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

주주 수익률

	PAYS	US Diversified Financial	US 마켓
7D	-10.3%	-0.04%	-1.2%
1Y	41.0%	32.4%	30.4%

수익률 대 산업: PAYS 지난 1년 동안 32.4 %를 반환한 US Diversified Financial 산업을 초과했습니다.

수익률 대 시장: PAYS 지난 1년 동안 30.4 %를 반환한 US 시장을 초과했습니다.

가격 변동성

Is PAYS's price volatile compared to industry and market?
PAYS volatility
PAYS Average Weekly Movement	6.5%
Diversified Financial Industry Average Movement	5.1%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.5%
10% least volatile stocks in US Market	3.1%

안정적인 주가: PAYS 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: PAYS 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
1995	123	Mark Newcomer	www.paysign.com

는 기업, 소비자 및 정부 기관을 위한 선불 카드 프로그램, 종합적인 환자 경제성 제품, 디지털 뱅킹 서비스 및 통합 결제 처리 서비스를 제공합니다. 제공하는 제품에는 기업 보상, 선불 기프트 카드, 범용 충전식 직불 카드, 직원 인센티브, 소비자 리베이트, 기증자 보상, 임상 시험, 의료비 환급 결제 및 의약품 결제 지원, 직불 카드로 액세스 가능한 요구불 계좌를 위한 솔루션이 포함됩니다. 이 회사는 Paysign 브랜드로 선불 카드 솔루션을 판매합니다.

Paysign, Inc. 기본 사항 요약

Paysign 의 수익과 매출은 시가총액과 어떻게 비교하나요?
PAYS 기본 통계
시가총액	US$176.71m
수익(TTM)	US$8.07m
수익(TTM)	US$56.47m

21.9x

P/E 비율

3.1x

P/S 비율

PAYS 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
PAYS 손익 계산서(TTM)
수익	US$56.47m
수익 비용	US$26.33m
총 이익	US$30.14m
기타 비용	US$22.07m
수익	US$8.07m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)	0.15
총 마진	53.37%
순이익 마진	14.28%
부채/자본 비율	0%

PAYS 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

PAYS 주식 개요

보상

위험 분석

Paysign, Inc. 경쟁사

NasdaqGS:CASS

US$601.0m

NasdaqCM:IMXI

US$651.2m

NasdaqGS:CTLP

US$653.2m

NasdaqGM:USIO

US$40.2m

가격 내역 및 성능

최근 뉴스 및 업데이트

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind